The net effect is simple: After weight loss, people are hungrier, feel less satisfied after eating and burn fewer calories than expected
However, you should always defer to the specific instructions provided by the licensed provider and the dispensing pharmacy
These data are a cornerstone in our research and build on our understanding of how MASH and cardiometabolic conditions like type 2 diabetes, obesity, dyslipidemia [abnormal fat levels in the blood], and high blood pressure are interrelated. Metabolic dysfunction-associated steatotic liver disease (MASLD), occurs when abnormal amounts of fat accumulate in the liver in the presence of cardiometabolic risk factors such as type 2 diabetes, obesity, high blood levels of cholesterol or other fats, or high blood pressure
Effects of OnceWeekly Semaglutide on Appetite, Energy Intake, Control of Eating, Food Preference and Body Weight in Subjects with Obesity. Diabetes, Obesity and Metabolism 19(9):12421251